Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None USD 0.00(0%)
Last update at 2026-02-19T21:03:21.365479Z
Market Cap
1460.00M

Momentum Score

…

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers artisanal cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
2.53
Low
5.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
927.19M
Revenue Per Share
2.72
Gross Profit TTM
415.55M
Debt / Equity
-
ROE
-17.95%
Net Debt
328.15M
ROCE
-2.47%
Diluted EPS TTM
-0.77

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -163.40M 91.96M -0.32M -0.08M -
Minority interest -0.29M -2.51M 0.34M 5.09M 2.80M
Net income -269.16M -14.68M -0.32M -0.08M -
Selling general administrative 356.57M 188.18M 0.30M 0.08M -
Gross profit 423.06M 334.56M - - -
Reconciled depreciation 150.32M 96.24M - - -
Ebit - 185.59M 92.31M -3.10M 8.30M
Ebitda 36.35M 212.47M -0.30M -0.08M -
Operating income -49.66M 104.60M -0.30M -0.08M -
Other operating expenses - - - - 28.00M
Interest expense 49.43M 24.27M 0.02M 0.01M 0.00M
Tax provision 105.47M 104.13M 0.00M -0.00M -
Net interest income -49.43M -24.27M -0.02M -0.01M -
Income tax expense 105.47M 104.13M 42.30M 10.33M 1.77M
Total revenue 879.41M 737.85M 0.00M 0.00M -
Total operating expenses 929.07M 633.25M 0.30M 0.08M -
Cost of revenue 456.35M 403.29M - - -
Total other income expense net -64.31M 11.63M - - -
Discontinued operations - - -1.97M -1.97M -1.97M
Net income from continuing ops -268.87M -12.17M -0.32M -0.08M -
Net income applicable to common shares -269.16M -269.16M 38.40M -18.27M -0.56M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2396.05M 2545.72M 0.02M 0.00M -
Intangible assets 1180.77M 1379.91M - - -
Other current assets 48.88M 19.53M - - -
Total liab 1054.51M 1066.99M 0.30M 0.11M -
Total stockholder equity 1341.55M 1475.78M -0.28M -0.10M -
Other current liab - 364.82M 76.55M 25.83M 9.70M
Common stock - 1488.19M 137.91M 111.75M 123.38M
Capital stock 1665.96M 1488.19M 1.18M 1.08M -
Retained earnings -324.40M -12.40M 9.25M -1.68M -
Other liab - 264.17M 16.86M 5.11M 0.82M
Good will 269.09M 368.13M - - -
Other assets - 2.50M 2.44M 3.81M 2.06M
Cash 84.85M 99.12M 0.01M 0.00M -
Total current liabilities 386.64M 469.86M 116.29M 56.34M 23.55M
Net debt 328.15M 190.81M 0.08M 0.07M -
Short long term debt 24.46M 13.77M 0.08M 0.07M -
Property plant equipment - 513.58M 155.97M 104.24M 40.75M
Total current assets 318.27M 273.98M 71.25M 50.19M 93.87M
Long term investments 6.98M 7.63M - - -
Net tangible assets -108.30M -272.26M 58.71M 86.81M 108.69M
Net receivables 16.58M 17.70M 11.32M 10.39M 3.80M
Long term debt 388.54M 276.15M - - -
Inventory 164.53M 137.63M 37.35M 30.69M 15.96M
Accounts payable 40.50M 45.17M 18.29M 18.54M 7.81M
Non currrent assets other 12.77M - - - -
Non current assets total 2077.78M 2271.75M 0.00M 0.00M -
Capital lease obligations 85.74M 63.38M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -207.85M -3.35M -3.35M -9.91M -1.75M
Change to liabilities 0.00M 9.92M 1.22M 3.90M 5.66M
Total cashflows from investing activities - -454.16M -86.91M -84.12M -29.35M
Net borrowings - 213.97M 24.19M 17.26M -2.26M
Total cash from financing activities 99.25M 355.68M 25.27M 24.11M 94.29M
Change to operating activities - 3.93M 9.64M -2.70M -6.86M
Net income -269.16M -14.68M 38.40M -18.27M -0.56M
Change in cash -14.26M 82.72M 9.98M -66.67M 69.76M
Begin period cash flow 99.12M 16.40M 0.00M 0.00M -
End period cash flow 84.85M 99.12M 0.01M 0.00M 0.00M
Total cash from operating activities 94.35M 181.20M 71.63M -6.66M 4.82M
Issuance of capital stock - 0.00M 0.11M 0.00M -
Depreciation 150.32M 96.24M 7.87M 7.39M 2.57M
Other cashflows from investing activities - 14.59M 3.70M -4.43M -1.61M
Dividends paid 0.00M 0.00M 0.05M 6.10M 0.87M
Change to inventory -24.23M -59.51M -22.87M -8.37M -2.07M
Change to account receivables 0.82M -6.67M -2.51M -2.62M -1.72M
Other cashflows from financing activities - 141.71M -1.07M 4.87M -3.37M
Change to netincome - 72.34M 1.73M 2.68M 4.63M
Capital expenditures 119.17M 141.26M 60.15M 59.04M 21.46M
Change in working capital -38.03M 15.77M 0.08M 0.00M -
Stock based compensation 39.05M 0.74M 0.00M 0.01M -
Other non cash items -0.28M 80.32M 0.01M 0.00M -
Free cash flow -24.83M 31.56M -0.23M -0.07M -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
0.13
0.39%
33.80 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
169.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
-
-%
20.84 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Verano Holdings Corp

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers artisanal cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.

415 North Dearborn Street, Chicago, IL, United States, 60654

312 265 0730

3780

Name Title Year Born
Mr. George P. Archos Founder, Chairman & CEO 1979
Mr. John Tipton Pres 1961
Mr. Darren Weiss Esq. COO, Chief Legal Officer, Gen. Counsel & Sec. 1984
Mr. Samuel Dorf Co-Founder & Chief Growth Officer NA
Mr. Brett Summerer Chief Financial Officer 1977
Mr. Aaron Miles Chief Investment Officer 1979
Julianna Paterra C.F.A. Director of Investor Relations NA
Mr. David Spreckman Exec. VP & Head of Marketing 1990
Ms. Destiny Thompson Chief People Officer 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…